AR032695A1 - Composicion farmaceutica - Google Patents
Composicion farmaceuticaInfo
- Publication number
- AR032695A1 AR032695A1 ARP020100516A ARP020100516A AR032695A1 AR 032695 A1 AR032695 A1 AR 032695A1 AR P020100516 A ARP020100516 A AR P020100516A AR P020100516 A ARP020100516 A AR P020100516A AR 032695 A1 AR032695 A1 AR 032695A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- thieno
- benzylamino
- pyrimidin
- benzo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Composicion farmacéutica de elevada biodisponibilidad para la administracion oral de ácido 4-[4-(3-cloro-4-metoxi-bencilamino)-benzo [4,5] tieno [2,3-d]pirimidin-2-il]-ciclohexancarboxílico y/o ácido 4-[4-(3-cloro-4hidroxi-bencilamino)-benzo[4,5]tieno[2,3]-dpirimidin-2-il]-ciclohexancarboxílico o de sus sales aptas para uso farmacéutico, con un procedimiento para preparar la composicion farmacéutica y con su uso.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10107261A DE10107261B4 (de) | 2001-02-16 | 2001-02-16 | Pharmazeutische Zusammensetzung |
Publications (1)
Publication Number | Publication Date |
---|---|
AR032695A1 true AR032695A1 (es) | 2003-11-19 |
Family
ID=7674278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020100516A AR032695A1 (es) | 2001-02-16 | 2002-02-15 | Composicion farmaceutica |
Country Status (21)
Country | Link |
---|---|
US (1) | US20040082600A1 (es) |
EP (1) | EP1385521A2 (es) |
JP (1) | JP2004519489A (es) |
KR (1) | KR20030074822A (es) |
CN (1) | CN1649592A (es) |
AR (1) | AR032695A1 (es) |
BR (1) | BR0207271A (es) |
CA (1) | CA2438401A1 (es) |
CZ (1) | CZ20032423A3 (es) |
DE (1) | DE10107261B4 (es) |
EC (1) | ECSP034769A (es) |
EE (1) | EE200300378A (es) |
HU (1) | HUP0303141A3 (es) |
IL (1) | IL157411A0 (es) |
MX (1) | MXPA03007318A (es) |
PE (1) | PE20021039A1 (es) |
PL (1) | PL364467A1 (es) |
RU (1) | RU2003127393A (es) |
SK (1) | SK11352003A3 (es) |
WO (1) | WO2002072100A2 (es) |
ZA (1) | ZA200307216B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101065115A (zh) * | 2004-11-24 | 2007-10-31 | 默克公司 | 取代酰胺的液体和半固体口服药物制剂 |
WO2013109354A2 (en) * | 2011-12-07 | 2013-07-25 | Texas Southern University | Etravirine formulations and uses thereof |
JP6943384B2 (ja) * | 2017-03-01 | 2021-09-29 | ヱスビー食品株式会社 | 食品の食感劣化防止用ソフトカプセル、並びに、該食感劣化防止用ソフトカプセル及び食用油を含有する食品 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL102003A0 (en) * | 1991-06-03 | 1992-12-30 | Merck Sharp & Dohme | Pharmaceutical formulation of a benzodiazepine |
DE19819023A1 (de) * | 1998-04-29 | 1999-11-04 | Merck Patent Gmbh | Thienopyrimidine |
DE19928146A1 (de) * | 1999-06-19 | 2000-12-21 | Merck Patent Gmbh | Thienopyrimidine |
AU2001228454A1 (en) * | 2000-01-13 | 2001-07-24 | Merck Patent G.M.B.H | Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary |
DE10001021A1 (de) * | 2000-01-13 | 2001-07-19 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
-
2001
- 2001-02-16 DE DE10107261A patent/DE10107261B4/de not_active Expired - Fee Related
-
2002
- 2002-01-23 JP JP2002571059A patent/JP2004519489A/ja not_active Withdrawn
- 2002-01-23 WO PCT/EP2002/000609 patent/WO2002072100A2/en not_active Application Discontinuation
- 2002-01-23 RU RU2003127393/15A patent/RU2003127393A/ru not_active Application Discontinuation
- 2002-01-23 MX MXPA03007318A patent/MXPA03007318A/es unknown
- 2002-01-23 IL IL15741102A patent/IL157411A0/xx unknown
- 2002-01-23 KR KR10-2003-7010607A patent/KR20030074822A/ko not_active Application Discontinuation
- 2002-01-23 US US10/467,788 patent/US20040082600A1/en not_active Abandoned
- 2002-01-23 CZ CZ20032423A patent/CZ20032423A3/cs unknown
- 2002-01-23 EE EEP200300378A patent/EE200300378A/xx unknown
- 2002-01-23 CA CA002438401A patent/CA2438401A1/en not_active Abandoned
- 2002-01-23 BR BR0207271-8A patent/BR0207271A/pt not_active IP Right Cessation
- 2002-01-23 CN CNA028050061A patent/CN1649592A/zh active Pending
- 2002-01-23 HU HU0303141A patent/HUP0303141A3/hu unknown
- 2002-01-23 SK SK1135-2003A patent/SK11352003A3/sk not_active Application Discontinuation
- 2002-01-23 PL PL02364467A patent/PL364467A1/xx unknown
- 2002-01-23 EP EP02701263A patent/EP1385521A2/en not_active Withdrawn
- 2002-02-15 AR ARP020100516A patent/AR032695A1/es not_active Application Discontinuation
- 2002-02-15 PE PE2002000135A patent/PE20021039A1/es not_active Application Discontinuation
-
2003
- 2003-09-15 EC EC2003004769A patent/ECSP034769A/es unknown
- 2003-09-15 ZA ZA200307216A patent/ZA200307216B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ECSP034769A (es) | 2003-12-24 |
CN1649592A (zh) | 2005-08-03 |
WO2002072100A3 (en) | 2003-11-06 |
RU2003127393A (ru) | 2005-01-20 |
BR0207271A (pt) | 2004-03-23 |
CZ20032423A3 (en) | 2004-07-14 |
SK11352003A3 (sk) | 2003-12-02 |
WO2002072100A2 (en) | 2002-09-19 |
MXPA03007318A (es) | 2003-12-04 |
DE10107261B4 (de) | 2005-03-10 |
PL364467A1 (en) | 2004-12-13 |
DE10107261A1 (de) | 2002-09-12 |
HUP0303141A3 (en) | 2006-05-29 |
IL157411A0 (en) | 2004-03-28 |
EE200300378A (et) | 2003-10-15 |
CA2438401A1 (en) | 2002-09-19 |
HUP0303141A2 (hu) | 2003-12-29 |
KR20030074822A (ko) | 2003-09-19 |
EP1385521A2 (en) | 2004-02-04 |
US20040082600A1 (en) | 2004-04-29 |
PE20021039A1 (es) | 2002-11-14 |
ZA200307216B (en) | 2005-01-13 |
JP2004519489A (ja) | 2004-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60209145D1 (de) | Pharmazeutische formulierungen mit platinderivaten | |
AR029471A1 (es) | Forma cristalina de la sal de disodio del acido n- [4- [2-(2-amino-4,7-dihidro-4-oxo-3h-pirrolo[2,3-d]pirimidin-5-il)etil]benzoil] -l-glutrmico-forma cristalina heptahidrato-; procedimiento de uso de dicha forma en la fabricacion de medicamentos para el tratamiento del cancer; formulaciones farmaceu | |
NO20063231L (no) | Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer | |
AR038527A1 (es) | Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo | |
ECSP034774A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
NO20023527D0 (no) | Pyrido(2,3-d)pyrimidin-2,7-diamin kinaseinhibitorer | |
AR055099A1 (es) | Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol | |
CR8102A (es) | Derivados de pirazolo- quinazolina, procedimiento para preparacion y su uso como inhibidores de quinasa | |
NO20032909L (no) | Glukopyranosyloksypyrazolderivater samt medikamentell anvendelse derav | |
DK1383752T3 (da) | Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser | |
ATE267601T1 (de) | Pharmazeutische zusammensetzung enthaltend pemetrexed zusammen mit monothioglycerol, l- cystein oder thioglykolsäure | |
BR0112847A (pt) | Uso de uma forma de dosagem sólida | |
ATE415949T1 (de) | Pharmazeutische formulierung mit levothyroxin- natrium | |
BRPI0510820A (pt) | composição farmacêutica, forma unitária de dosagem e seus usos | |
IL195837A0 (en) | 4-amino-3-arylamino-6-arylpyrazolo[3,4-d] | |
HRP20090190T1 (en) | Pharmaceutical composition comprising a salt of mirtazapine | |
AR032695A1 (es) | Composicion farmaceutica | |
AR027624A1 (es) | Forma de dosificacion oral para la administracion de la combinacion de tegafur, uracilo y acido folinico, y oxaliplatino y metodo de uso de los mismos | |
PA8519501A1 (es) | Farnesil transferasa inhibidora del enantiomero de quinolina 1,2-anillado | |
ATE479428T1 (de) | Olanzapin enthaltende pharmazeutische zusammensetzung | |
AU2003257982A1 (en) | Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage | |
SV2002000112A (es) | Complejo farmaceutico ref.pcs10331aksr/bb | |
HN2000000057A (es) | Derivados de i - trifluorometil-4-hidroxi-7-piperidinil- aminometilcromano. | |
AR029091A1 (es) | Uso de compuestos de 1-amino-5-fenilpentano-3-ol y/o 1-amino-6-fenilhexano-3-ol para la preparacion de un medicamento con efecto antagonista de n-metil-d-aspartato-(nmda) | |
BR0209956A (pt) | Uso da 4- (2-fluorofenil)-6-metil-2- (1-piperazinil)tieno [2,3-d]pirimidina para o tratamento da dor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |